Myeloproliferative neoplasm other imaging findings

Jump to navigation Jump to search

Myeloproliferative Neoplasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating myeloproliferative neoplasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myeloproliferative neoplasm other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myeloproliferative neoplasm other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myeloproliferative neoplasm other imaging findings

on Myeloproliferative neoplasm other imaging findings

Myeloproliferative neoplasm other imaging findings in the news

Blogs on Myeloproliferative neoplasm other imaging findings

Directions to Hospitals Treating Myeloproliferative neoplasm

Risk calculators and risk factors for Myeloproliferative neoplasm other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]

Overview

Other imaging studies for myeloproliferative neoplasm include positron emission tomography (PET) scan, which helps to detect metastasis in bone marrow and to follow up medical treatment.

PET scan

Positron emission tomography (PET) scan can be done to assess for hypermetabolic activity in bone marrow, lymph nodes, and other organs.[1] PET scan can help diagnose an underlying malignancy associated with myeloproliferative neoplasm, such as lymphoma. PET scan can also assess for enlargement of the spleen and hypermetabolic activity in the spleen. Of note, a PET scan is not standard of care in patients with myeloproliferative neoplasm but can be of diagnostic utility if other imaging modalities, such as CT scan, are nondiagnostic.


References

  1. Agool A, Glaudemans AW, Boersma HH, Dierckx RA, Vellenga E, Slart RH (2011). "Radionuclide imaging of bone marrow disorders". Eur J Nucl Med Mol Imaging. 38 (1): 166–78. doi:10.1007/s00259-010-1531-0. PMC 3005118. PMID 20625724.

Template:WH Template:WS